Avita Medical | 1811094D - Trade Creditors



Avita Medical reported 6.29M in Trade Creditors for its fiscal semester ending in December of 2024.


Trade Creditors Change Date
Adcock Ingram Holdings 1.16B 941.66M Jun/2024
Celltrion KRW 106.69B 31.38B Mar/2025
Cochlear AUD 285.5M 17.7M Dec/2024
CSL USD 2.98B 2.11B Dec/2024
Cspc Pharmaceutical CNY 2.04B 548.01M Dec/2024
Dianthus Therapeutics USD 5.4M 825K Jun/2025
Divis Laboratories Ltd 9.1B 550M Mar/2025
Kangmei Pharma CNY 2.43B 2.26M Jun/2025
Laboratorios Farma EUR 57.21M 29.64M Jun/2025
Malin Corporation EUR 0 500K Dec/2024
Mayne Pharma AUD 20.87M 21.9M Jun/2024
Medical Developments International AUD 5.15M 3.11M Dec/2024
Nanosonics AUD 10.08M 6.61M Dec/2024
Neuren Pharmaceuticals 1.45M 3.03M Dec/2024
Organigram Holdings 89.8M 26.46M Jun/2025
Pacific Edge 2.64M 489K Mar/2025
Paradigm Biopharmaceuticals AUD 580.84K 2.24M Dec/2024
Pharma Mar EUR 37.08M 4.92M Jun/2025
Polynovo AUD 6.39M 2.84M Jun/2024
PYC Therapeutics AUD 7.53M 116.62K Jun/2024
Qiagen NV USD 82.34M 12.67M Jun/2025
Ramsay Health Care 1.65B 1.31B Jun/2024
ResMed USD 278.16M 57.85M Jun/2025
Sartorius EUR 384.2M 24.6M Jun/2025
Sino Biopharmaceutical CNY 1.5B 685.94M Dec/2024
Telix Pharmaceuticals AUD 68.7M 46.4M Dec/2024
Tilray USD 99.08M 2.79M Nov/2024
Zz Pientze Pharmaceu 484.61M 53.88M Jun/2025